1. Ling T#, Li S, Chen H, Huan Chen, Qiuping Wang, Jing Shi, Yirong Li, Wenjun Bao, Kunming Liang, & Hai-long Piao*. Lysine-372-dependent SUMOylation inhibits the enzymatic activity of glutamine synthases. FASEB J, 2023, 37(12):e23319.
2. Ling T#, Weng G. X, Li J, Li C, Wang W. Cao, L Rao H, Ju C, & Xu, L. G*. TARBP2 inhibits IRF7 activation by suppressing TRAF6-mediated K63-linked ubiquitination of IRF7. Molecular immunology, 2019, 109, 116–125.
3. Ling T#, Li S. N, Weng G. X, Wang W. Li, C Cao, L Rao. H, Shu H. B, & Xu, L. G*. TARBP2 negatively regulates IFN-β production and innate antiviral response by targeting MAVS. Molecular immunology, 2018, 104, 1–10.
4. 凌婷#, 石京, 冯婷泽, 裴劭君, 李思怿, 朴海龙*. 细胞转录组学和代谢组学整合策略表征突变影响谷氨酰胺合成酶酶活的关键代谢通路[J]. 色谱, 2025, 43 (3): 207-219.
5. Li S. N#, Ling T#, Yang Y. X, Huang J. P, & Xu L. G*. CHID1 positively regulates RLR antiviral signaling by targeting the RIG-I/VISA signalosome. Journal of medical virology, 2019, 91(9), 1668–1678.
6. Zhong N#, Wang C, Weng G, Ling T*, & Xu, L*. (2023). ZNF205 positively regulates RLR antiviral signaling by targeting RIG-I. Acta biochimica et biophysica Sinica, 2023, 55(10), 1582–1591.